Influenza in the Time of COVID 19 Webinar


Influenza in the Time of COVID 19 Webinar Banner



Date & Location
Wednesday, February 9, 2022, 3:00 PM - Thursday, February 9, 2023, 4:00 PM

Target Audience
Specialties - Adolescent Medicine, Allergy and Immunology, Developmental-Behavioral Pediatrics, Family Medicine, Hospitalist, Infectious Disease, Internal Medicine-Pediatrics, Nursing, Pediatric Infectious Diseases, Pediatrics, Pharmacy, Preventive Medicine, Public Health, Pulmonary Disease

Overview

This webinar will provide an update on influenza in the US and considerations for managing it during the current COVID 19 pandemic.

Launch Date: 2/9/2022

Expiration Date: 2/9/2023

 



Objectives
At the conclusion of this activity, participants should be able to:

  1. Identify scope of influenza disease in US during current COVID 19 pandemic

Registration

How to obtain continuing education credits after viewing the webinar: 

1. Sign in or create a new account by clicking "Sign In" in top left corner. *If you previously participated in a CME activity accredited by IU but do not know your password, please enter your email address and click on the 'Forget Your Password' button. Your password will be emailed to you.
2. Click the Tests tile and Launch Website to view the webinar.
3. After the webinar, click the Tests tile to attest to completing the activity.
4. Click the MyCME button and click the Evaluations and Certificates tile. 
5. Choose the Type of Credit, complete the CME Evaluation, and click Submit.
6. On the Evaluations and Certificates page, click Download Certificate.

Participants must view the entire webinar and submit a completed evaluation via survey monkey after the event to receive 1.0 contact hours and CNE Certificate:https://www.surveymonkey.com/r/CarricoJan

If you have questions in regards to Nursing CE’s please contact Lori Lovett at [email protected].


Accreditation
 
In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and Indiana Immunization Coalition. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists
Indiana University School of Medicine designates this activity for 1.0 ACPE contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Physicians
Indiana University School of Medicine designates this enduring activity for a maximum of 1.0AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nurses
Indiana Immunization Coalition (IIC) is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91).

References: 

1.       Media centre. Influenza (seasonal). World Health Organization website. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed December 10, 2020.

2.        CDC. https://www.cdc.gov/flu/about/burden/index.html. Accessed December 10, 2020.

3.       CDC. https://gis.cdc.gov/grasp/fluview/pedfludeath.html. Accessed September 18, 2019.

4.       NFID. http://www.nfid.org/idinfo/influenza/cta-dangers-of-influenza-in-adults-with-chronic-health-c.pdf. Updated September 2018. Accessed December 10, 2020.

5.       CDC. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed December 10, 2020.

6.       Ciszewski A. Vaccine. 2018;36:202-206.

7.       CDC. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed December 10, 2020.

8.        Ciszewski A. Vaccine. 2018;36:202-206.

9.        NFID. http://www.nfid.org/idinfo/influenza/cta-dangers-of-influenza-in-adults-with-chronic-health-c.pdf. Updated September 2018. Accessed December 10, 2020.

10.   CDC. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed December 10, 2020.

11.   Ciszewski A. Vaccine. 2018;36:202-206.

12.    NFID. http://www.nfid.org/idinfo/influenza/cta-dangers-of-influenza-in-adults-with-chronic-health-c.pdf. Updated September 2018. Accessed December 10, 2020.

13.   CDC. https://www.cdc.gov/flu/symptoms/symptoms.htm. Accessed December 10, 2020.

14.   Ciszewski A. Vaccine. 2018;36:202-206.

15.    NFID. http://www.nfid.org/idinfo/influenza/cta-dangers-of-influenza-in-adults-with-chronic-health-c.pdf. Updated September 2018. Accessed December 10, 2020.

16.   CDC. https://gis.cdc.gov/grasp/fluview/FluHospChars.html. Accessed December 10, 2020.

17.   CDC. https://gis.cdc.gov/grasp/fluview/pedfludeath.html. Accessed August 29, 2019.

18.   CDC. https://www.cdc.gov/flu/about/burden/2017-2018.htm. Accessed July 31, 2019.

19.   CDC. MMWR. 2019;68(6):135-139.

20.   Shang M, et al. Pediatrics. 2018;141(4):e20172918.

21.   CDC. https://gis.cdc.gov/GRASP/Fluview/FluHospRates.html. Accessed December 30, 2020.

22.   Thompson MG, et al. Vaccine. 2018;36:5916-5925.

23.   Warren-Gash C, et al. Eur Respir J. 2018;51.

24.   MacIntyre CR, et al. Heart. 2016;102:1953-1956. 

25.   Modin D, et al. Circulation. 2019;139:575-586.

26.   American Diabetes Association. https://www.diabetes.org/newsroom/press-releases/2019/flu-vaccinations. Accessed December 10, 2020.

27.   WHO. https://www.who.int/immunization/IA2030_draft_4_WHA.pdf?ua=1. Accessed December 15, 2020.

28.   CDC. https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Accessed December 15, 2020.

29.   CDC. https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Accessed December 15, 2020.

30.   CDC. https://www.cdc.gov/flu/season/protect-your-health.html. Accessed December 15, 2020.

31.   CDC. https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Accessed December 15, 2020.

32.   Sanofi Pasteur Inc. Data on file, 2020.

33.   Office of Disease Prevention and Health Promotion. Immunization and infectious diseases. Healthy People 2030.  https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination. Accessed January 28, 2021.

34.   Sanofi Pasteur Inc. Data on File, 2018.

35.   CDC. https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html. Accessed December 10, 2020. 

36.   CDC. MMWR. 2020;69(8):1-24.

37.   Sanofi Pasteur Inc. Data on File, 2016.

38.   Nichol KL, et al. J Gen Intern Med. 1996;11:673-677.

39.   National Foundation for Infectious Diseases. December 4, 2019. https://www.nfid.org/2019/12/04/why-we-must-recommend-flu-vaccine-to-patients-with-chronic-health-conditions/.

40.   Schuchat A, et al. http://www.vicnetwork.org/wp-content/uploads/VICNetwork12-18-13_Slides.pdf. Accessed July 31, 2019.

41.   CDC. https://www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm. Accessed January 7, 2021.

42.   CDC. https://www.cdc.gov/flu/prevent/misconceptions.htm. Accessed December 10, 2020.

43.   Sah P, et al. Proc Natl Acad Sci U S A. 2018;115:5151-5156.

44.   CDC. https://www.cdc.gov/flu/prevent/misconceptions.htm. Accessed December 10, 2020.

45.   CDC. https://www.cdc.gov/flu/about/burden/index.html. Accessed December 10, 2020.

46.   CDC. https://www.cdc.gov/flu/about/keyfacts.htm. Accessed December 10, 2020.

47.   NFID. http://www.nfid.org/idinfo/influenza/cta-dangers-of-influenza-in-adults-with-chronic-health-c.pdf. Updated September 2018. Accessed December 10, 2020.

48.   CDC. https://gis.cdc.gov/grasp/fluview/FluHospChars.html. Accessed December 10, 2020.

49.   Ciszewski A. Vaccine. 2018;36:202-206.

50.   MacIntyre CR, et al. Heart. 2016;102:1953-1956.

51.   Thompson MG, et al. Vaccine. 2018;36:5916-5925.

52.   CDC. https://www.cdc.gov/vaccines/pandemic-guidance/index.html. Accessed December 15, 2020.

53.   American Diabetes Association. https://www.diabetes.org/newsroom/press-releases/2019/flu-vaccinations. Accessed December 10, 2020.

54.   CDC. MMWR. 2018;67(3):1-20. 11. Nichol KL, et al. J Gen Intern Med. 1996;11:673-677.


Additional Information

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected] One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.


Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), ACPE Contact Hours (1.00 hours)